FDA
approval
· 2017-11-02
FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Micro Labs Limited)
Summary
FDA approves an original generic application for a fixed-dose combination tablet of amlodipine and olmesartan medoxomil by Micro Labs Limited for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)